Literature DB >> 28597065

Cellular and molecular pathways of structural damage in rheumatoid arthritis.

Ulrike Harre1, Georg Schett2.   

Abstract

Structural damage of cartilage and bone tissue is a hallmark of rheumatoid arthritis (RA). The resulting joint destruction constitutes one of the major disease consequences for patients and creates a significant burden for the society. The main cells executing bone and cartilage degradation are osteoclasts and fibroblast-like synoviocytes, respectively. The function of both cell types is heavily influenced by the immune system. In the last decades, research has identified several mediators of structural damage, ranging from infiltrating immune cells and inflammatory cytokines to autoantibodies. These factors result in an inflammatory milieu in the affected joints which leads to an increased development and function of osteoclasts and the transformation of fibroblast-like synoviocytes towards a highly migratory and destructive phenotype. In addition, repair mechanisms mediated by osteoblasts and chondrocytes are strongly impaired by the presence of pro-inflammatory cytokines. This article will review the current knowledge on the mechanisms of joint inflammation and the destruction of bone and cartilage.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28597065     DOI: 10.1007/s00281-017-0634-0

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  79 in total

Review 1.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

2.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

3.  Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.

Authors:  S Kotake; K Sato; K J Kim; N Takahashi; N Udagawa; I Nakamura; A Yamaguchi; T Kishimoto; T Suda; S Kashiwazaki
Journal:  J Bone Miner Res       Date:  1996-01       Impact factor: 6.741

4.  Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.

Authors:  Lilian H D van Tuyl; Alexandre E Voskuyl; Maarten Boers; Piet Geusens; Robert B M Landewé; Ben A C Dijkmans; Willem F Lems
Journal:  Ann Rheum Dis       Date:  2010-06-04       Impact factor: 19.103

Review 5.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

6.  Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.

Authors:  A Deodhar; R K Dore; D Mandel; J Schechtman; W Shergy; R Trapp; P A Ory; C G Peterfy; T Fuerst; H Wang; L Zhou; W Tsuji; R Newmark
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

7.  Synovial fibroblasts spread rheumatoid arthritis to unaffected joints.

Authors:  Stephanie Lefèvre; Anette Knedla; Christoph Tennie; Andreas Kampmann; Christina Wunrau; Robert Dinser; Adelheid Korb; Eva-Maria Schnäker; Ingo H Tarner; Paul D Robbins; Christopher H Evans; Henning Stürz; Jürgen Steinmeyer; Steffen Gay; Jürgen Schölmerich; Thomas Pap; Ulf Müller-Ladner; Elena Neumann
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

8.  Interleukin-1 beta is a potent inhibitor of bone formation in vitro.

Authors:  P Stashenko; F E Dewhirst; M L Rooney; L A Desjardins; J D Heeley
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

9.  Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis.

Authors:  Nicole C Walsh; Susan Reinwald; Catherine A Manning; Keith W Condon; Ken Iwata; David B Burr; Ellen M Gravallese
Journal:  J Bone Miner Res       Date:  2009-09       Impact factor: 6.741

10.  Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.

Authors:  Lorraine Yeo; Kai-Michael Toellner; Mike Salmon; Andrew Filer; Christopher D Buckley; Karim Raza; Dagmar Scheel-Toellner
Journal:  Ann Rheum Dis       Date:  2011-07-08       Impact factor: 19.103

View more
  23 in total

1.  Rheumatoid arthritis: from basic findings and clinical manifestations to future therapies.

Authors:  Paul Hasler; Cem Gabay
Journal:  Semin Immunopathol       Date:  2017-06-21       Impact factor: 9.623

Review 2.  3D Bioprinting: from Benches to Translational Applications.

Authors:  Marcel Alexander Heinrich; Wanjun Liu; Andrea Jimenez; Jingzhou Yang; Ali Akpek; Xiao Liu; Qingmeng Pi; Xuan Mu; Ning Hu; Raymond Michel Schiffelers; Jai Prakash; Jingwei Xie; Yu Shrike Zhang
Journal:  Small       Date:  2019-04-29       Impact factor: 13.281

3.  Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment.

Authors:  Shinya Hayashi; Tsukasa Matsubara; Toshihisa Maeda; Koji Fukuda; Keiko Funahashi; Marowa Hashimoto; Ken Tsumiyama; Tomoyuki Kamenaga; Yoshinori Takashima; Tomoyuki Matsumoto; Shotaro Tachibana; Ryosuke Kuroda
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Macrophages mediate corticotomy-accelerated orthodontic tooth movement.

Authors:  Yan Wang; Hanwen Zhang; Wen Sun; Siyu Wang; Shuting Zhang; Linlin Zhu; Yali Chen; Lizhe Xie; Zongyang Sun; Bin Yan
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

5.  Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target.

Authors:  Serena Bugatti; Laura Bogliolo; Antonio Manzo; Ludovico De Stefano; Paolo Delvino; Francesca Motta; Carlomaurizio Montecucco
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

6.  CircMAPK9 promotes the progression of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-140-3p/PPM1A axis.

Authors:  Zhihuan Luo; Shaojian Chen; Xiaguang Chen
Journal:  J Orthop Surg Res       Date:  2021-06-21       Impact factor: 2.359

7.  Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis.

Authors:  Mehreen Inam Illahi; Sofia Amjad; Syed Mehfooz Alam; Syed Tousif Ahmed; Murk Fatima; Moazzam A Shahid
Journal:  Cureus       Date:  2021-05-29

8.  Long Non-Coding RNA GAPLINC Promotes Tumor-Like Biologic Behaviors of Fibroblast-Like Synoviocytes as MicroRNA Sponging in Rheumatoid Arthritis Patients.

Authors:  Bi Yao Mo; Xing Hua Guo; Meng Ru Yang; Fang Liu; Xuan Bi; Yan Liu; Lin Kai Fang; Xi Qing Luo; Julie Wang; Joseph A Bellanti; Yun Feng Pan; Song Guo Zheng
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

9.  MiR-199a-3p inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via suppressing retinoblastoma 1.

Authors:  Yufan Wangyang; Linhong Yi; Tao Wang; Yanbo Feng; Guangwang Liu; Dongya Li; Xin Zheng
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

10.  Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis.

Authors:  Ben Gorissen; Alain de Bruin; Alberto Miranda-Bedate; Nicoline Korthagen; Claudia Wolschrijn; Teun J de Vries; René van Weeren; Marianna A Tryfonidou
Journal:  J Cell Physiol       Date:  2018-06-22       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.